The role of genetic testing in soft tissue sarcoma

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Soft tissue tumors are a diverse group of mesenchymal lesions.
• Classification is evolving with advances in cytogenetic and molecular techniques.
• Molecular diagnostic tools are increasingly supplementing traditional methods.

Purpose of the Study:

• To review the application of genetic testing in soft tissue sarcoma diagnosis and prognosis.
• To provide a realistic appraisal of molecular techniques' ancillary role, including benefits and limitations.

Main Methods:

• Review of current literature on molecular genetics in soft tissue sarcomas.
• Discussion of cytogenetic (karyotyping, FISH) and molecular genetic (PCR, sequencing) techniques.
• Focus on genetic alterations like translocations, mutations, amplifications, and deletions.

Main Results:

• Molecular genetics is integral for diagnosing specific tumors, like paediatric small blue round cell tumours.
• Sarcomas can be broadly classified into those with specific genetic alterations (simple karyotypes) and those with non-specific alterations (complex karyotypes).
• Specific examples include FUS-DDIT3 translocations in myxoid liposarcoma and KIT mutations in gastrointestinal stromal tumours.

Conclusions:

• Genetic testing is crucial for the diagnosis and prognosis of soft tissue sarcomas.
• Molecular techniques offer significant advantages but also have limitations.
• The integration of molecular genetics enhances the diagnostic work-up for soft tissue sarcomas.